BRAF and MEK Inhibitor Side Effects in BRAF V600E–Mutated NSCLC
BRAF and MEK Inhibitor Side Effects in BRAF V600E–Mutated NSCLC

Melissa Johnson, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

How To Manage Side Effects of EGFR Inhibitors in NSCLC
How To Manage Side Effects of EGFR Inhibitors in NSCLC

Azam Farooqui, MD, Joshua Sabari, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Key Adverse Effects of Novel Antibody-Drug Conjugates in NSCLC
Key Adverse Effects of Novel Antibody-Drug Conjugates in NSCLC

Jacob Sands, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Optimizing ROS1 Inhibitor Therapy in NSCLC
Optimizing ROS1 Inhibitor Therapy in NSCLC

Estelamari Rodriguez, MD, MPH, Rohit Gosain, MD, Rahul Gosain, MD, MBA

How to Manage Anti-EGFR Toxicities in NSCLC
How to Manage Anti-EGFR Toxicities in NSCLC

Gilberto Lopes, MD